1 - 25 of 1,053 results for author:"Kim J.-H." in Literature citations
Results Customize
› Repeat search in UniProtKB (24,316)
| First report of human acute acalculous cholecystitis caused by the fish pathogen Lactococcus garvieae. Kim J.H., Go J., Cho C.R., Kim J.I., Lee M.S., Park S.C. J. Clin. Microbiol. 51:712-714(2013) · UniProtKB (1) |
| Characterization of mutations associated with the adaptation of a low-pathogenic H5N1 avian influenza virus to chicken embryos. Kim I.H., Kwon H.J., Choi J.G., Kang H.M., Lee Y.J., Kim J.H. Vet. Microbiol. 162:471-478(2013) · UniProtKB (16) |
| Complete genome sequence of bacteriophage phiAC-1 infecting Acinetobacter soli strain KZ-1. Kim J.H., Oh C., Choresca C.H., Shin S.P., Han J.E., Jun J.W., Heo S.J., Kang D.H., Park S.C. J. Virol. 86:13131-13132(2012) · UniProtKB (82) |
| Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production. Park S.W., Cho C.S., Jun H.O., Ryu N.H., Kim J.H., Yu Y.S., Kim J.S., Kim J.H. Invest. Ophthalmol. Vis. Sci. 53:7718-7726(2012) · Mapped (5) |
| Nanog signaling in cancer promotes stem-like phenotype and immune evasion. Noh K.H., Kim B.W., Song K.H., Cho H., Lee Y.H., Kim J.H., Chung J.Y., Kim J.H., Hewitt S.M., Seong S.Y. et al. J. Clin. Invest. 122:4077-4093(2012) · Mapped (2) |
| Implication of intestinal VDR deficiency in inflammatory bowel disease. Kim J.H., Yamaori S., Tanabe T., Johnson C.H., Krausz K.W., Kato S., Gonzalez F.J. Biochim. Biophys. Acta 1830:2118-2128(2013) · Mapped (3) |
| Adora2b adenosine receptor signaling protects during acute kidney injury via inhibition of neutrophil-dependent TNF-alpha release. Grenz A., Kim J.H., Bauerle J.D., Tak E., Eltzschig H.K., Clambey E.T. J. Immunol. 189:4566-4573(2012) · Mapped (12) |
| Regulation of human growth and differentiation factor 3 gene expression by NANOG in human embryonic carcinoma NCCIT cells. Park S.W., Lim H.Y., Do H.J., Sung B., Huh S.H., Uhm S.J., Song H., Chung H.J., Kim J.H., Kim N.H. et al. FEBS Lett. 586:3529-3535(2012) · Mapped (4) |
| Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Rolland M., Edlefsen P.T., Larsen B.B., Tovanabutra S., Sanders-Buell E., Hertz T., deCamp A.C., Carrico C., Menis S., Magaret C.A. et al. Nature 490:417-420(2012) · UniProtKB (5,094) |
| The lack of CD34 expression in gastrointestinal stromal tumors is related to cystic degeneration following imatinib use. Koh Y., Lee H.E., Oh D.Y., Kim J.H., Lee S.H., Kim S.H., Kim D.W., Im S.A., Kim T.Y., Heo D.S. et al. Jpn. J. Clin. Oncol. 42:1020-1027(2012) · Mapped (9) |
| Chemical genetics reveals a specific requirement for Cdk2 activity in the DNA damage response and identifies Nbs1 as a Cdk2 substrate in human cells. Wohlbold L., Merrick K.A., De S., Amat R., Kim J.H., Larochelle S., Allen J.J., Zhang C., Shokat K.M., Petrini J.H. et al. PLoS Genet. 8:e1002935-e1002935(2012) · Mapped (3) |
| Intracellular interaction of interleukin (IL)-32alpha with protein kinase Cepsilon (PKCepsilon ) and STAT3 protein augments IL-6 production in THP-1 promonocytic cells. Kang J.W., Park Y.S., Lee D.H., Kim J.H., Kim M.S., Bak Y., Hong J., Yoon D.Y. J. Biol. Chem. 287:35556-35564(2012) · Mapped (20) |
| CD28-B7 interaction modulates short- and long-lived plasma cell function. Njau M.N., Kim J.H., Chappell C.P., Ravindran R., Thomas L., Pulendran B., Jacob J. J. Immunol. 189:2758-2767(2012) · Mapped (25) |
| ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy. Kim J.W., Kim J.H., Im S.A., Kim Y.J., Han H.S., Kim J.S., Han S.W., Jeon Y.K., Oh D.Y., Han W. et al. Oncology 83:218-227(2012) · Mapped (16) |
| Tumor necrosis factor-alpha promoter polymorphisms are associated with idiopathic primary ovarian insufficiency in Korean women. Kim J.H., Jeon Y.J., Rah H., Lee B.E., Choi D.H., Lee W.S., Kim N.K. Fertil. Steril. 98:1260-5.e1-2(2012) · Mapped (6) |
| Association between FGFR1OP2/wit3.0 polymorphisms and residual ridge resorption of mandible in Korean population. Kim J.H., Oh M.Y., Paek J., Lee J. PLoS ONE 7:e42734-e42734(2012) · Mapped (1) |
| RNA-binding properties and RNA chaperone activity of human peroxiredoxin 1. Kim J.H., Lee J.M., Lee H.N., Kim E.K., Ha B., Ahn S.M., Jang H.H., Lee S.Y. Biochem. Biophys. Res. Commun. 425:730-734(2012) · Mapped (2) |
| Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis. Lee E.W., Kim J.H., Ahn Y.H., Seo J., Ko A., Jeong M., Kim S.J., Ro J.Y., Park K.M., Lee H.W. et al. Nat Commun 3:978-978(2012) · Mapped (3) |
| First description of ColE-type plasmid in Aeromonas spp. carrying quinolone resistance (qnrS2) gene. Han J.E., Kim J.H., Choresca C.H. Jr., Shin S.P., Jun J.W., Chai J.Y., Park S.C. Lett. Appl. Microbiol. 55:290-294(2012) · UniProtKB (8) |
| Potential association between ANXA4 polymorphisms and aspirin-exacerbated respiratory disease. Park T.J., Kim J.H., Bae J.S., Park B.L., Cheong H.S., Pasaje C.F., Park J.S., Uh S.T., Kim M.K., Choi I.S. et al. Diagn. Mol. Pathol. 21:164-171(2012) · Mapped (9) |
| Inhibition of MKK7-JNK by the TOR signaling pathway regulator-like protein contributes to resistance of HCC cells to TRAIL-induced apoptosis. Song I.S., Jun S.Y., Na H.J., Kim H.T., Jung S.Y., Ha G.H., Park Y.H., Long L.Z., Yu D.Y., Kim J.M. et al. Gastroenterology 143:1341-1351(2012) · Mapped (3) |
| TLR7 recognition is dispensable for influenza virus A infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice. Jeisy-Scott V., Kim J.H., Davis W.G., Cao W., Katz J.M., Sambhara S. J. Virol. 86:10988-10998(2012) · Mapped (14) |
| Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Adrianto I., Wang S., Wiley G.B., Lessard C.J., Kelly J.A., Adler A.J., Glenn S.B., Williams A.H., Ziegler J.T., Comeau M.E. et al. Arthritis Rheum. 64:3695-3705(2012) · Mapped (17) |
| Proteomic identification of ADAM12 as a regulator for TGF-beta1-induced differentiation of human mesenchymal stem cells to smooth muscle cells. Kim Y.M., Kim J., Heo S.C., Shin S.H., Do E.K., Suh D.S., Kim K.H., Yoon M.S., Lee T.G., Kim J.H. PLoS ONE 7:e40820-e40820(2012) · Mapped (11) |
| Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity. Jeon H., Kim J.H., Kim J.H., Lee W.H., Lee M.S., Suk K. J Neuroinflammation 9:149-149(2012) · Mapped (4) |